Search Results - Guillermo Rossiter

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease

    Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease by MW Babyatsky, Guillermo Rossiter, DK Podolsky

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia

    Effect of nifedipine on sphincter of Oddi motor activity: Studies in healthy volunteers and patients with biliary dyskinesia by Moisés Guelrud, Sonia Mendoza, Guillermo Rossiter, Luisa Ramirez, Jamie S. Barkin

    Published 1988
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease

    Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease by Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Bin Li, Keith Usiskin, Xiaojiang Zhan, Jean‐Frédéric Colombel

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial

    Vedolizumab for the prevention of intestinal acute GVHD after allogeneic hematopoietic stem cell transplantation: a randomized phase 3 trial by Yi‐Bin Chen, Mohamad Mohty, Robert Zeiser, Takanori Teshima, Omer Jamy, Johan Maertens, Duncan Purtill, Jingjing Chen, Hongcui Cao, Guillermo Rossiter, Johan Jansson, Yngvar Fløisand

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study

    Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study by Jeffrey S. Hyams, Dan Turner, Stanley A. Cohen, Erzsébet Szakos, Kinga Kowalska‐Duplaga, Frank M. Ruemmele, Nicholas M. Croft, Bartosz Korczowski, Promise Lawrence, Siddharth Bhatia, Harisha Kadali, Chun‐Lin Chen, Wan Sun, Maria Rosario, Senthil Kabilan, William R. Treem, Guillermo Rossiter, Richard A. Lirio

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: